According to the results of two brand new studies, – the new Roche anti-arthritis drug, which has been tasted, is effective in relieving the symptoms of rheumatoid arthritis in children as well as in adults.
It works by blocking the interleukin-6 receptor, which is a molecule involved in promoting the painful inflammation in rheumatoid arthritis.
As it was done in these studies, tocilizumab isn’t so placebo, convinced especially for adults. This is a expert opinion, but it better drug than existing medications.
Related News:
- FDA approves Actemra to treat rare form of juvenile arthritis
- FDA examines ways to improve consumer understanding of prescription drug ads
- FDA Drug Safety Communication: Antipsychotic drug labels updated on use during pregnancy and risk of abnormal muscle movements and withdrawal symptoms in newborns
- FDA Drug Safety Communication: Children born to mothers who took Valproate products while pregnant may have impaired cognitive development
- FDA approves Potiga to treat seizures in adults